Investigations of cosmonauts' peripheral red blood prior to and on days 1, 7 and 14 post long-term MIR-19 and -20 missions dealt with the morphological composition of blood, indices of iron exchange, correlation of erythrocyte shapes, and the lipid and phospholipid profiles of the erythrocyte membrane. To this avail, methods of light electron microscopy, radioimmune analysis, and thin-layer microscopy were used. Among the unidirectional shifts in the crewmembers of these missions were changes in ion exchange indices and the lipid and phospholipid profiles of erythrocyte membrane which were indicative of increased microviscosity of the lipid layer. Number of erythrocytes and hemoglobin content were reduced; transformed erythrocytes were present. It was also discovered that the fraction of normal erythrocytes (diskocytes) was partially replaced by spherocytes, cnisocytes in flight and typically by echinocytosis post flight. By and large, the observed shifts do not have any clinical implications and are most likely the blood system reaction to the stress of readaptation to the terrestrial conditions.

Download full-text PDF

Source

Publication Analysis

Top Keywords

peripheral red
8
red blood
8
lipid phospholipid
8
phospholipid profiles
8
profiles erythrocyte
8
erythrocyte membrane
8
[influence space
4
space flight
4
flight factors
4
factors peripheral
4

Similar Publications

(1) Background: Fetal chromosomal examination is a critical component of modern prenatal testing. Traditionally, maternal serum biomarkers such as free β-human chorionic gonadotropin (Free β-HCG) and pregnancy-associated plasma protein A (PAPPA) have been employed for screening, achieving a detection rate of approximately 90% for fetuses with Down syndrome, albeit with a false positive rate of 5%. While amniocentesis remains the gold standard for the prenatal diagnosis of chromosomal abnormalities, including Down syndrome and Edwards syndrome, its invasive nature carries a significant risk of complications, such as infection, preterm labor, or miscarriage, occurring at a rate of 7 per 1000 procedures.

View Article and Find Full Text PDF

Hereditary transthyretin amyloidosis (ATTRv) is an autosomal-dominant systemic disease, where amyloid fibrils accumulate especially in the peripheral and autonomic nervous systems and in the heart. The aim of the present work was to outline the follow-up and type of management received by asymptomatic carriers (ACs) and stage 1 ATTRv patients in Spain. A cross-sectional, non-interventional study was conducted throughout seven experienced hospitals in Spain.

View Article and Find Full Text PDF

The neurotransmitter acetylcholine (ACh) is essential in both the central and peripheral nervous systems. Recent studies highlight the significance of interactions between ACh and various neuromodulators in regulating complex behaviors. The ability to simultaneously image ACh and other neuromodulators can provide valuable information regarding the mechanisms underlying these behaviors.

View Article and Find Full Text PDF

Chronic kidney disease (CKD) patients often suffer from complications such as anemia as the kidney function declines. More than 25% of CKD hemodialysis patients in China are complicated with renal anemia due to renal and hepatic impairment in the production of erythropoietin (EPO). In recent years, prolyl hydroxylase domain (PHD) inhibitors have been approved in China and Japan for the treatment of CKD patients complicated with anemia.

View Article and Find Full Text PDF
Article Synopsis
  • RVS has shown promising anticancer effects in past studies, but its impact on T cells in immuno-oncology requires further exploration.
  • RVS treatment significantly boosts the anticancer activity of T cells, with notable increases in cytotoxicity against specific breast cancer cell lines.
  • The study suggests that RVS can restore T cell function by lowering PD-1 expression, indicating its potential role in cancer therapy.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!